Skip to main content
SpringerLink
Log in

Cutaneous Manifestations of Hyperthyroidism

  • Chapter
Thyroid Disorders with Cutaneous Manifestations

  • 1126 Accesses

Editorial Perspective

The key to diagnosing hyperthyroidism from a dermatologic perspective is based on having a high index of suspicion that excess thyroid hormone is responsible for the patient's signs and symptoms. As there are no definitive cutaneous manifestations of hyperthyroidism, a careful review of systems may yield important clinical clues to the diagnosis: Is the patient intolerant of heat? Has there been weight loss? Has the patient experienced any palpitations? Have the bowel habits changed? The unique challenge lies in when systemic symptoms are absent or vague, and the skin manifestations are subtle. Should one routinely check a thyroid-stimuating hormone (TSH) level when the only dermatologic finding is onycholysis? Should one obtain a TSH level before administering botulinum toxin for axillary hyperhidrosis with an otherwise unremarkable review of systems? Should you check thyroid function studies for patients presenting with alopecia areata? There are no definitive answers to these questions. Obviously, the yield will be higher in those patients who have several signs and symptoms referable to a hyperthyroid state. It is my opinion that for isolated findings, such as onycholysis or palmoplantar hyperhidrosis, with an unremarkable review of systems, screening for hyperthyroidism is not mandatory. On the other hand, I believe that it is appropriate to check a TSH level in a woman presenting with alopecia, even if there are no associated constitutional symptoms. When patients present with other autoimmune diseases (i.e., chronic idi-opathic urticaria, dermatitis herpetiformis, lichen sclerosus, etc.) in which there is an increased risk for autoimmune thyroid disease, I think it is reasonable to check for thyroid autoantibodies (anti-thryroglobulin, antithyroid peroxidase), especially if there is a positive family history for autoimmune diseases (notably diabetes mellitus or autoimmune thyroid disease). If positive, these patients may be at a greater risk for the development of autoimmune thyroid disease and should be screened periodically (every 3–5 years) with a TSH assay unless clinical circumstances dictate otherwise. In this era of evidence-based medicine, diagnosing hyperthyroidism is still founded on clinical acumen. Fortunately, a clinician's suspicions are easily confirmed or refuted by straightforward laboratory testing. Maintaining an appropriate index of suspicion for hyperthyroidism will allow patients to be diagnosed and treated expediently, thereby greatly increasing their quality of life

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002;87:489–499.

    Article  PubMed  CAS  Google Scholar 

  2. Leese GP, Flynn RV, Jung RT, Macdonald TM, Murphy MJ, Morris AD. Increasing prevalence and incidence of thyroid disease in Tayside, Scotland: the Thyroid Epidemiology Audit and Research Study (TEARS). Clin Endocrinol (Oxf) 2007 Oct 29 [epub ahead of print].

    Google Scholar 

  3. Stanbury JB, Ermans AE, Bourdoux P, et al. Iodine-induced hyperthyroidism: occurrence and epidemiology. Thyroid 1998;8:83–100.

    Article  PubMed  CAS  Google Scholar 

  4. Safer JD, Crawford TM, Fraser LM, et al. Thyroid hormone action on skin: diverging effects of topical versus intraperitoneal administration. Thyroid 2003;13:159–165.

    Article  PubMed  CAS  Google Scholar 

  5. Gout S, Morin C, Houle F, Huot J. Death receptor-3, a new E-Selectin counter-receptor that confers migration and survival advantages to colon carcinoma cells by triggering p38 and ERK MAPK activation. Cancer Res 2006;66:9117–9124.

    Article  PubMed  CAS  Google Scholar 

  6. Braverman LE, Utiger RD. Introduction to thyro-toxicosis. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's: The Thyroid. 7th ed. Philadelphia: Lippincott-Raven; 1996:453–455.

    Google Scholar 

  7. Davies TF, Larsen PR. Thyrotoxicosis. In: Wilson GM, Foster D, Kronenberg M, Larsen PR, eds. Williams Textbook of Endocrinology. Philadelphia: Saunders; 2002, 333–368.

    Google Scholar 

  8. Heymann WR. Cutaneous manifestations of thyroid disease. J Am Acad Dermatol 1992;26:885–902.

    Article  PubMed  CAS  Google Scholar 

  9. Ramanathan M, Abidin MN, Muthukumarappan M. The prevalence of skin manifestations in thyro-toxicosis—a retrospective study. Med J Malaysia 1989;44:324–328.

    PubMed  CAS  Google Scholar 

  10. Jabbour SA. Cutaneous manifestations of endocrine disorders: a guide for dermatologists. Am J Clin Dermatol 2003;4:315–331.

    Article  PubMed  Google Scholar 

  11. Heymann WR. The skin in thyrotoxicosis. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's The Thyroid: A Functional and Clinical Text. Philadelphia: Lippincott Williams and Wilkins; 2000, 593–595.

    Google Scholar 

  12. Carlson HE. Gynecomastia. N Engl J Med 1980;303 795–799.

    Article  PubMed  CAS  Google Scholar 

  13. Dabon-Almirante CL, Surks MI. Clinical and laboratory diagnosis of thyrotoxicosis. Endocrinol Metab Clin North Am 1998;27:25–35.

    Article  PubMed  CAS  Google Scholar 

  14. Gibinski K, Powierza-Kaczynska C, Zmudzinski J, Giec L, Dosiak J. Thyroid control of sweat gland function. Metabolism 1972;21:843–848.

    Article  PubMed  CAS  Google Scholar 

  15. Kim YD, Lee EJ, Song MH, Suhr KB, Lee JH, Park JK. Multiple eccrine hidrocystomas associated with Graves' disease. Int J Dermatol 2002;41: 295–297.

    Article  PubMed  Google Scholar 

  16. Goolamali SK, Evered D, Shuster S. Thyroid disease and sebaceous function. Br Med J 1976;1(6007):432– 433.

    Article  PubMed  CAS  Google Scholar 

  17. Thody AJ, Shuster S. Control and function of sebaceous glands. Physiol Rev 1989;69:383–416.

    PubMed  CAS  Google Scholar 

  18. Ebling FJ. Hormonal control and methods of measuring sebaceous gland activity. J Invest Dermatol 1974;62:161–171.

    Article  PubMed  CAS  Google Scholar 

  19. Ahsan MK, Urano Y, Kato S, Oura H, Arase S. Immunohistochemical localization of thyroid hormone nuclear receptors in human hair follicles and in vitro effect of L-triiodothyronine on cultured cells of hair follicles and skin. J Med Invest 1998;44:179– 184.

    PubMed  CAS  Google Scholar 

  20. Billoni N, Buan B, Gautier B, Gaillard O, Mahe YF, Bernard BA. Thyroid hormone receptor beta1 is expressed in the human hair follicle. Br J Dermatol 2000;142:645–652.

    Article  PubMed  CAS  Google Scholar 

  21. Zamboni G, Camilot M, Francia G, et al. Thyroxine hair content in congenital hypothyroidism and hyper-thyroidism. J Pediatr Endocrinol Metab 2003;16:379–382.

    Article  PubMed  CAS  Google Scholar 

  22. Alonso LC, Rosenfield RL. Molecular genetic and endocrine mechanisms of hair growth. Horm Res 2003;60:1–13.

    Article  PubMed  CAS  Google Scholar 

  23. Safer JD, Fraser LM, Ray S, Holick MF. Topical triiodothyronine stimulates epidermal proliferation, dermal thickening, and hair growth in mice and rats. Thyroid 2001;11:717–724.

    Article  PubMed  CAS  Google Scholar 

  24. Niepomniszcze H, Amad RH. Skin disorders and thyroid diseases. J Endocrinol Invest 2001;24:628–638.

    PubMed  CAS  Google Scholar 

  25. Leonhardt JM, Heymann WR. Thyroid disease and the skin. Dermatol Clin 2002;20:473–481, vii.

    Article  PubMed  Google Scholar 

  26. Ghayee HK, Mattern JQ 3rd, Cooper DS. Dirty nails. J Clin Endocrinol Metab 2005;902428.

    Google Scholar 

  27. Lambert WC. Cutaneous deposition disorders. In: Farmer ER, Hood AF, eds. Pathology of the Skin. Norwalk, CT: Appleton and Lange; 1990:432.

    Google Scholar 

  28. Matsuoka LY, Wortsman J, Uitto J, et al. Altered skin elastic fibers in hypothyroid myxedema and pretibial myxedema. Arch Intern Med 1985;145:117–121.

    Article  PubMed  CAS  Google Scholar 

  29. Komosinska-Vassev K, Winsz-Szczotka K, Olczyk K, Kozma EM. Alterations in serum glycosaminoglycan profiles in Graves' patients. Clin Chem Lab Med 2006;44:582–588.

    Article  PubMed  CAS  Google Scholar 

  30. Klein I, Danzi S. Thyroid disease and the heart. Circulation 2007;116:1725–1735.

    Article  PubMed  Google Scholar 

  31. Nayak B, Hodak SP. Hyperthyroidism. Endocrinol Metab Clin North Am 2007;36:617–656, v.

    Article  PubMed  CAS  Google Scholar 

  32. Vargas F, Moreno JM, Rodriguez-Gomez I, et al. Vascular and renal function in experimental thyroid disorders. Eur J Endocrinol 2006;154:197–212.

    Article  PubMed  CAS  Google Scholar 

  33. Ojamaa K, Balkman C, Klein IL. Acute effects of triiodothyronine on arterial smooth muscle cells. Ann Thorac Surg 1993;56(1 suppl):S61–S66; discussion S66–S67.

    Article  PubMed  CAS  Google Scholar 

  34. Fukuyama K, Ichiki T, Imayama I, et al. Thyroid hormone inhibits vascular remodeling through suppression of cAMP response element binding protein activity. Arterioscler Thromb Vasc Biol 2006;26:2049–2055.

    Article  PubMed  CAS  Google Scholar 

  35. Kossard S, Winkelmann RK. Vascular calcification in dermatopathology. Am J Dermatopathol 1979;1:27–34.

    PubMed  CAS  Google Scholar 

  36. Buckley R, Smith KJ, Skelton HG. Generalized essential telangiectasia in a patient with Graves' disease: should the spectrum of autoimmune diseases associated with generalized telangiectasia be expanded? Cutis 2000;65:175–177.

    PubMed  CAS  Google Scholar 

  37. Kavak A, Kutluay L. Unilateral nevoid telangiectasia and hyperthyroidism: a new association or coincidence? J Dermatol 2004;31:411–414.

    PubMed  Google Scholar 

  38. Liel Y. Livedo reticularis: a rare manifestation of Graves hyperthyroidism associated with anticardioli-pin antibodies. South Med J 2004;97:601–603.

    Article  PubMed  Google Scholar 

  39. Ligier S, Pham CD, Watters AK, Kassis J, Fortin PR. Purpura fulminans and anticardiolipin antibodies in a patient with Grave's disease. Scand J Rheumatol 2002;31:371–373.

    Article  PubMed  Google Scholar 

  40. Nakayama T, Yamamoto T, Kanmatsuse K, Kokubun S. Graves' disease associated with anticar-diolipin antibody positivity and acquired protein S deficiency. Rheumatol Int 2003;23:198–200.

    Article  PubMed  Google Scholar 

  41. Thomas RD, Croft DN. Thyrotoxicosis and giant-cell arteritis. Br Med J 1974;2(5916):408–409.

    Article  PubMed  CAS  Google Scholar 

  42. Tandon R, Fahy R. Giant cell arteritis in a patient with acute aortic insufficiency with thyrotoxicosis. Clin Rheumatol 2006;25:254–257.

    Article  PubMed  Google Scholar 

  43. Kettaneh A, Prevot S, Biaggi A, et al. Hyperthyroidism in two patients with Crohn disease and Takayasu arteritis. Scand J Gastroenterol 2003;38:901–903.

    Article  PubMed  CAS  Google Scholar 

  44. Fatourechi V. Pretibial myxedema: pathophysiol-ogy and treatment options. Am J Clin Dermatol 2005;6:295–309.

    Article  PubMed  Google Scholar 

  45. Garrity JA, Bahn RS. Pathogenesis of graves ophthalmopathy: implications for prediction, prevention, and treatment. Am J Ophthalmol 2006;142: 147–153.

    Article  PubMed  CAS  Google Scholar 

  46. Bartley GB, Gorman CA. Diagnostic criteria for Graves' ophthalmopathy. Am J Ophthalmol 1995;119:792–795.

    PubMed  CAS  Google Scholar 

  47. Gaddipati RV, Meyer DR. Eyelid retraction, lid lag, lagophthalmos, and von Graefe's sign quantifying the eyelid features of Graves' ophthalmopathy. Ophthalmology 2007 Sept 25 [epub ahead of print].

    Google Scholar 

  48. Coulter I, Frewin S, Krassas GE, Perros P. Psychological implications of Graves' orbitopathy. Eur J Endocrinol 2007;157:127–131.

    Article  PubMed  CAS  Google Scholar 

  49. Bahn RS, Dutton CM, Natt N, Joba W, Spitzweg C, Heufelder AE. Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: potential autoantigen in Graves' ophthalmopathy. J Clin Endocrinol Metab 1998;83:998–1002.

    Article  PubMed  CAS  Google Scholar 

  50. Higuchi T, Satoh T, Yokozeki H, Katayama I, Nishioka K. Palpebral edema as a cutaneous manifestation of hyperthyroidism. J Am Acad Dermatol 2003;48:617–619.

    Article  PubMed  Google Scholar 

  51. Wexler JA, Sharretts J. Thyroid and bone. Endocrinol Metab Clin North Am 2007;36:673–705, vi.

    Article  PubMed  CAS  Google Scholar 

  52. Vestergaard P, Mosekilde L. Fractures in patients with hyperthyroidism and hypothyroidism: a nationwide follow-up study in 16,249 patients. Thyroid 2002;12:411–419.

    Article  PubMed  Google Scholar 

  53. Numbenjapon N, Costin G, Gilsanz V, Pitukcheewanont P. Low cortical bone density measured by computed tomography in children and adolescents with untreated hyperthyroidism. J Pediatr 2007;150:527–530.

    Article  PubMed  Google Scholar 

  54. Fatourechi V, Ahmed DD, Schwartz KM. Thyroid acropachy: report of 40 patients treated at a single institution in a 26-year period. J Clin Endocrinol Metab 2002;87:5435–5441.

    Article  PubMed  CAS  Google Scholar 

  55. Tran HA. Thyroid acropachy. Intern Med J 2004;34:513–514.

    Article  PubMed  CAS  Google Scholar 

  56. Anderson CK, Miller OF 3rd. Triad of exoph-thalmos, pretibial myxedema, and acropachy in a patient with Graves' disease. J Am Acad Dermatol 2003;48:970–972.

    Article  PubMed  Google Scholar 

  57. Casey BM, Leveno KJ. Thyroid disease in pregnancy. Obstet Gynecol 2006;108:1283–1292.

    Article  PubMed  CAS  Google Scholar 

  58. Kalb RE, Grossman ME. The association of aplasia cutis congenita with therapy of maternal thyroid disease. Pediatr Dermatol 1986;3:327–330.

    Article  PubMed  CAS  Google Scholar 

  59. Anselmo J, Cao D, Karrison T, Weiss RE, Refetoff S. Fetal loss associated with excess thyroid hormone exposure. JAMA 2004;292:691–695.

    Article  PubMed  CAS  Google Scholar 

  60. Poppe K, Velkeniers B, Glinoer D. Thyroid disease and female reproduction. Clin Endocrinol (Oxf) 2007;66:309–321.

    Article  CAS  Google Scholar 

  61. Trokoudes KM, Skordis N, Picolos MK. Infertility and thyroid disorders. Curr Opin Obstet Gynecol 2006;18:446–451.

    Article  PubMed  Google Scholar 

  62. Zimmerman D. Fetal and neonatal hyperthyroidism. Thyroid 1999;9:727–733.

    Article  PubMed  CAS  Google Scholar 

  63. Chan GW, Mandel SJ. Therapy insight: management of Graves' disease during pregnancy. Nat Clin Pract Endocrinol Metab 2007;3:470–478.

    Article  PubMed  CAS  Google Scholar 

  64. O'Connor MJ, Paget-Brown AO, Clarke WL. Premature twins of a mother with Graves' disease with discordant thyroid function: a case report. J Perinatol 2007;27:388–389.

    Article  PubMed  Google Scholar 

  65. Kopp P, van Sande J, Parma J, et al. Brief report: congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor gene. N Engl J Med 1995;332:150–154.

    Article  PubMed  CAS  Google Scholar 

  66. Nishihara E, Fukata S, Hishinuma A, et al. Sporadic congenital hyperthyroidism due to a germline mutation in the thyrotropin receptor gene (Leu 512 Gln) in a Japanese patient. Endocr J 2006;53(735– 740.

    Article  PubMed  CAS  Google Scholar 

  67. Fu J, Jiang Y, Liang L, Zhu H. Risk factors of primary thyroid dysfunction in early infants born to mothers with autoimmune thyroid disease. Acta Paediatr 2005;94:1043–1048.

    Article  PubMed  Google Scholar 

  68. Skuza KA, Sills IN, Stene M, Rapaport R. Prediction of neonatal hyperthyroidism in infants born to mothers with Graves disease. J Pediatr 1996;128:264–268.

    Article  PubMed  CAS  Google Scholar 

  69. Yoshimoto M, Nakayama M, Baba T, et al. A case of neonatal McCune-Albright syndrome with Cushing syndrome and hyperthyroidism. Acta Paediatr Scand 1991;80:984–987.

    Article  PubMed  CAS  Google Scholar 

  70. Bunevicius R, Prange AJ Jr. Psychiatric manifestations of Graves' hyperthyroidism: pathophysiology and treatment options. CNS Drugs 2006;20: 897–909.

    Article  PubMed  Google Scholar 

  71. Peiris AN, Oh E, Diaz S. Psychiatric manifestations of thyroid disease. South Med J 2007;100:773–774.

    Article  PubMed  Google Scholar 

  72. Ordas DM, Labbate LA. Routine screening of thyroid function in patients hospitalized for major depression or dysthymia? Ann Clin Psychiatry 1995;7:161–165.

    Article  PubMed  CAS  Google Scholar 

  73. Wegener M, Wedmann B, Langhoff T, Schaffstein J, Adamek R. Effect of hyperthyroidism on the transit of a caloric solid-liquid meal through the stomach, the small intestine, and the colon in man. J Clin Endocrinol Metab 1992;75:745–749.

    Article  PubMed  CAS  Google Scholar 

  74. Krassas GE. Thyroid disease and female reproduction. Fertil Steril 2000;74:1063–1070.

    Article  PubMed  CAS  Google Scholar 

  75. Doufas AG, Mastorakos G. The hypothalamic-pituitary-thyroid axis and the female reproductive system. Ann N Y Acad Sci 2000;900:65–76.

    Article  PubMed  CAS  Google Scholar 

  76. Krassas GE, Perros P. Prevention of thyroid associated-ophthalmopathy in children and adults: current views and management of preventable risk factors. Pediatr Endocrinol Rev 2007;4:218–224.

    PubMed  Google Scholar 

  77. Krassas GE, Pontikides N. Male reproductive function in relation with thyroid alterations. Best Pract Res Clin Endocrinol Metab 2004;18:183–195.

    Article  PubMed  CAS  Google Scholar 

  78. Burman KD, McKinley-Grant L. Dermatologic aspects of thyroid disease. Clin Dermatol 2006;24:247–255.

    Article  PubMed  Google Scholar 

  79. Tan F, Nam TQ, Lee KO, Cheah WK, Mukherjee JJ. Recurrent episodes of arthritis in a hyperthyroid patient. Singapore Med J 2006;47:163–165.

    PubMed  CAS  Google Scholar 

  80. Erem C, Yucel Y, Ya Z, Reis A, Kocak M, Hacihasanoglu A. Leukocytoclastic vasculitis: a rare manifestation of propylthiouracil hypersensitivity. Med Princ Pract 2005;14:366–369.

    Article  PubMed  Google Scholar 

  81. Metso S, Jaatinen P, Huhtala H, Auvinen A, Oksala H, Salmi J. Increased cardiovascular and cancer mortality after radioiodine treatment for hyperthyroidism. J Clin Endocrinol Metab 2007;92:2190–2196.

    Article  PubMed  CAS  Google Scholar 

  82. Cooper DS. Approach to the patient with sub-clinical hyperthyroidism. J Clin Endocrinol Metab 2007;92:3–9.

    Article  PubMed  CAS  Google Scholar 

  83. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004;291(2): 228–238.

    Article  PubMed  CAS  Google Scholar 

  84. Volden G. Successful treatment of chronic skin diseases with clobetasol propionate and a hydro-colloid occlusive dressing. Acta Derm Venereol 1992;72:69–71.

    PubMed  CAS  Google Scholar 

  85. Fatourechi V, Pajouhi M, Fransway AF. Dermopathy of Graves disease (pretibial myxedema). Review of 150 cases. Medicine (Baltimore) 1994;73:1–7.

    CAS  Google Scholar 

  86. Pineda AM, Tianco EA, Tan JB, Casintahan FA, Beloso MB. Oral pentoxifylline and topical clobeta-sol propionate ointment in the treatment of pretibial myxoedema, with concomitant improvement of Graves' ophthalmopathy. J Eur Acad Dermatol Venereol 2007;21:1441–1443.

    Article  PubMed  CAS  Google Scholar 

  87. Susser WS, Heermans AG, Chapman MS, Baughman RD. Elephantiasic pretibial myxedema: a novel treatment for an uncommon disorder. J Am Acad Dermatol 2002;46:723–726.

    Article  PubMed  Google Scholar 

  88. Terheyden P, Kahaly GJ, Zillikens D, Brocker EB. Lack of response of elephantiasic pretibial myxoedema to treatment with high-dose intravenous immunoglobulins. Clin Exp Dermatol 2003;28:224–226.

    Article  PubMed  CAS  Google Scholar 

  89. Modjtahedi SP, Modjtahedi BS, Mansury AM, et al. Pharmacological treatments for thyroid eye disease. Drugs 2006;66:1685–1700.

    Article  PubMed  CAS  Google Scholar 

  90. Mourits MP, van Kempen-Harteveld ML, Garcia MB, Koppeschaar HP, Tick L, Terwee CB. Radiotherapy for Graves' orbitopathy: randomised placebo-controlled study. Lancet 2000;355(9214):1505–1509.

    Article  PubMed  CAS  Google Scholar 

  91. Zoumalan CI, Cockerham KP, Turbin RE, et al. Efficacy of corticosteroids and external beam radiation in the management of moderate to severe thyroid eye disease. J Neuroophthalmol 2007;27:205–214.

    Article  PubMed  Google Scholar 

  92. Nielsen CH, El Fassi D, Hasselbalch HC, Bendtzen K, Hegedus L. B-cell depletion with rituximab in the treatment of autoimmune diseases. Graves' ophthalmopathy the latest addition to an expanding family. Expert Opin Biol Ther 2007;7:1061–1078.

    Article  PubMed  CAS  Google Scholar 

  93. Della Rocca RC. Thyroid-related orbitopathy: concepts and management. Facial Plast Surg 2007;23: 168–173.

    Article  CAS  Google Scholar 

  94. Bach-Huynh TG, Jonklaas J. Thyroid medications during pregnancy. Ther Drug Monit 2006;28: 431–441.

    Article  PubMed  CAS  Google Scholar 

  95. Iwayama H, Hosono H, Yamamoto H, Oshiro M, Ueda N. Aplasia cutis congenita with skull defect in a monozygotic twin after exposure to methima-zole in utero. Birth Defects Res A Clin Mol Teratol 2007;79:680–684.

    Article  PubMed  CAS  Google Scholar 

  96. Diav-Citrin O, Ornoy A. Teratogen update: antithyroid drugs-methimazole, carbimazole, and propylthiouracil. Teratology 2002;65:38–44.

    Article  PubMed  CAS  Google Scholar 

  97. Karg E, Bereg E, Gaspar L, Katona M, Turi S. Aplasia cutis congenita after methimazole exposure in utero. Pediatr Dermatol 2004;21:491–494.

    Article  PubMed  Google Scholar 

  98. Polak M, Legac I, Vuillard E, Guibourdenche J, Castanet M, Luton D. Congenital hyperthyroidism: the fetus as a patient. Horm Res 2006;65:235–242.

    Article  PubMed  CAS  Google Scholar 

  99. Milgraum SS, Mitchell AJ, Bacon GE, Rasmussen JE. Alopecia areata, endocrine function, and autoan-tibodies in patients 16 years of age or younger. J Am Acad Dermatol 1987;17:57–61.

    Article  PubMed  CAS  Google Scholar 

  100. Nanda A, Alsaleh QA, Al-Hasawi F, Al-Muzairai I. Thyroid function, autoantibodies, and HLA tissue typing in children with alopecia areata. Pediatr Dermatol 2002;19:486–491.

    Article  PubMed  Google Scholar 

  101. Puavilai S, Puavilai G, Charuwichitratana S, Sakuntabhai A, Sriprachya-Anunt S. Prevalence of thyroid diseases in patients with alopecia areata. Int J Dermatol 1994;33:632–633.

    Article  PubMed  CAS  Google Scholar 

  102. Callen JP, Weston WF, Chanda JJ. Dermatitis herpetiformis and thyrotoxicosis. Int J Dermatol 1979;18:219–221.

    PubMed  CAS  Google Scholar 

  103. Holmes RC, Black MM. Herpes gestationis. A possible association with autoimmune thyrotoxi-cosis (Graves' disease). J Am Acad Dermatol 1980;3:474–477.

    Article  PubMed  CAS  Google Scholar 

  104. Selva-O'Callaghan A, Mijares-Boeckh-Behrens T, Solans-Laque R, Molins-Vara T, Olive G, Vilardell-Tarres M. Dermatomyositis and Graves' disease. Clin Exp Rheumatol 2001;19:595–596.

    PubMed  Google Scholar 

  105. Zingrillo M, Errico M, Simone P, Bosman C, Fusilli S. A case of dermatomyositis associated with hypothyroidism and hypoparathyroidism after surgery for Graves' disease. J Endocrinol Invest 1990;13:949–950.

    PubMed  CAS  Google Scholar 

  106. Kamei N, Yamane K, Yamashita Y, et al. Anti-Ku antibody-positive scleroderma-dermatomyositis overlap syndrome developing Graves' disease and immune thrombocytopenic purpura. Intern Med 2002;41:1199–1203.

    Article  PubMed  Google Scholar 

  107. Shahin AA, Abdoh S, Abdelrazik M. Prolactin and thyroid hormones in patients with systemic sclerosis: correlations with disease manifestations and activity. Z Rheumatol 2002;61:703–709.

    Article  PubMed  CAS  Google Scholar 

  108. Antonelli A, Ferri C, Fallahi P, et al. Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis. Eur J Endocrinol 2007;156:431–437.

    Article  PubMed  CAS  Google Scholar 

  109. Marasini B, Ferrari PA, Solaro N, Selmi C. Thyroid dysfunction in women with systemic sclerosis. Ann N Y Acad Sci 2007;1108:305–311.

    Article  PubMed  CAS  Google Scholar 

  110. Miyagawa S, Kitamura W, Sakamoto K. Skin lesions associated with Sjogren's syndrome and anticytoplasmic antibodies in SLE patients. J Dermatol 1983;10:495–500.

    PubMed  CAS  Google Scholar 

  111. Strakosch CR, Joyner D, Wall JR. Thyroid-stimulating antibodies in patients with autoimmune disorders. J Clin Endocrinol Metab 1978;47:361– 365.

    Article  PubMed  CAS  Google Scholar 

  112. Rodrigue S, Laborde H, Catoggio PM. Systemic lupus erythematosus and thyrotoxicosis: a hitherto little recognised association. Ann Rheum Dis May 1989;48:424–427.

    Article  CAS  Google Scholar 

  113. Rosen K, Lindstedt G, Mobacken H, Nystrom E. Thyroid function in patients with pustulosis palmo-plantaris. J Am Acad Dermatol 1988;19:1009–1016.

    Article  PubMed  CAS  Google Scholar 

  114. Bakar O, Demircay Z, Ergun T. Epidermolysis bullosa acquisita associated with vitiligo, Graves' disease and nephrotic syndrome. Int J Dermatol 2004;43:378–380.

    Article  PubMed  Google Scholar 

  115. Weiss GR, Fehrenkamp SH, Tokaz LK, Sunderland MC. Vitiligo and Graves' disease following treatment of malignant melanoma with recombinant human interleukin 4. Dermatology 1996; 192:283–285.

    Article  PubMed  CAS  Google Scholar 

  116. Birmingham CL, Gritzner S, Gutierrez E. Hyperthyroidism in anorexia nervosa: case report and review of the literature. Int J Eat Disord 2006;39:619–620.

    Article  PubMed  Google Scholar 

  117. Riis AL, Gravholt CH, Djurhuus CB, et al. Elevated regional lipolysis in hyperthyroidism. J Clin Endocrinol Metab 2002;87:4747–4753.

    Article  PubMed  CAS  Google Scholar 

  118. Nedvidkova J, Haluzik M, Bartak V, et al. Changes of noradrenergic activity and lipolysis in the subcutaneous abdominal adipose tissue of hypo- and hyperthyroid patients: an in vivo microdialysis study. Ann N Y Acad Sci 2004;1018:541–549.

    Article  PubMed  CAS  Google Scholar 

  119. Mariash CN. Thyroid hormone and the adipocyte. J Clin Endocrinol Metab 2003;88:5603–5604.

    Article  PubMed  CAS  Google Scholar 

  120. Haluzik M, Nedvidkova J, Bartak V, et al. Effects of hypo- and hyperthyroidism on noradrenergic activity and glycerol concentrations in human subcutaneous abdominal adipose tissue assessed with microdialysis. J Clin Endocrinol Metab 2003;88: 5605–5608.

    Article  PubMed  CAS  Google Scholar 

  121. Kumar G, Chow JT, Klarich KW, Dean DS. Hyperthyroidism and atrial ayxoma—an intriguing cardio-endocrine association. J Am Soc Echocardiogr 2007;20:1413, e5–e7.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Dermatology, Cooper University Hospital, Camden, NJ, USA

    Clara-Dina Cokonis MD, RPh & Carrie W. Cobb MD

  2. Division of Dermatology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School at Camden, Marlton, NJ, USA

    Warren R. Heymann MD

  3. Department of Dermatology, SAUSHEC—Wilford Hall Medical Center, Lackland, TX, USA

    Chad M. Hivnor MD

Authors
  1. Clara-Dina Cokonis MD, RPh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carrie W. Cobb MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Warren R. Heymann MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chad M. Hivnor MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School at Camden, Marlton, NJ, USA

    Warren R. Heymann MD

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag London Limited

About this chapter

Cite this chapter

Cokonis, CD., Cobb, C.W., Heymann, W.R., Hivnor, C.M. (2008). Cutaneous Manifestations of Hyperthyroidism. In: Heymann, W.R. (eds) Thyroid Disorders with Cutaneous Manifestations. Springer, London. https://doi.org/10.1007/978-1-84800-187-9_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-84800-187-9_8

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84800-186-2

  • Online ISBN: 978-1-84800-187-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation